GeneBio Systems
Recombinant Human TNFR1/TNFRSF1A Protein (Fc Tag)
Recombinant Human TNFR1/TNFRSF1A Protein (Fc Tag)
SKU:PKSH033160
Couldn't load pickup availability
Size: 50μg
Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Others
Abbreviation: TNFR1;TNFRSF1A
Target Synonym: TNF-R1;TNF-RI;TNFAR;TNFR-I;TNFR1;Tumor necrosis factor receptor 1;Tumor necrosis factor receptor superfamily member 1A;Tumor necrosis factor receptor type I
Research Areas: Signal Transduction;Cell biology;Cardiovascular;Cancer;immunology;Stem cells
Conjugation:
Target Species: Human
Expression Host: HEK293 Cells
Application: Cell culture
Fusion tag: C-Fc
UNIProt ID: P19438
Accession: P19438
Background: Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) is a member of the tumor necrosis factor receptor superfamily. TNFRSF1A is one of the major receptors for the tumor necrosis factor-alpha. It can activate the transcription factor NF-κB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the human genetic disorder called tumor necrosis factor associated periodic syndrome (TRAPS) or periodic fever syndrome.
Concentration:
Activity: Measured by its ability to induce NF-κB reporter activity in HEK293 human embryonic kidney cells. Recombinant Human TNF RI inhibits a constant dose of 0.5ng/mL of Recombinant TNF alpha. The IC50 for this effect is 2.7 ng/mL.
Sequence: Leu30-Thr 211
Purity: > 95 % as determined by reducing SDS-PAGE.
Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution: Please refer to the printed manual for detailed information.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 47.2 kDa
ObservedMW: 60 kDa
